Korro Bio
KRRO
49 hedge funds and large institutions have $28.1M invested in Korro Bio in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 14 reducing their positions, and 10 closing their positions.
1,892% more call options, than puts
Call options by funds: $239K | Put options by funds: $12K
99% more capital invested
Capital invested by funds: $14.1M → $28.1M (+$14M)
0.03% less ownership
Funds ownership: 0.45% → 0.42% (-0.03%)
11% less funds holding
Funds holding: 55 → 49 (-6)
50% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 14
60% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 10
Top Buyers
Top Sellers
| 1 |
BlackRock
New York
|
-$574K |
| 2 |
E
Ergoteles
New York
|
-$190K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$106K |
| 4 |
Millennium Management
New York
|
-$79.7K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$45K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CSS
51
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$23K | -258 | Closed |
|
52
Balyasny Asset Management
Chicago,
Illinois
| – | -$21K | -235 | Closed |
|
|
LP
53
LMR Partners
London,
United Kingdom
| – | -$21K | -231 | Closed |
|
54
Verition Fund Management
Greenwich,
Connecticut
| – | -$18K | -205 | Closed |
|
55
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$1.24K | -12 | Closed |
|
56
Citigroup
New York
| – | -$1K | -8 | Closed |
|
|
CUAMC
57
China Universal Asset Management Company
Shanghai,
China
| – | -$1K | -7 | Closed |
|
KRRO Hedge Fund Activity: Q4 2022 in Review
49 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Korro Bio (KRRO) for Q4 2022, worth a combined $28.1M — up 99% from $14.1M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of KRRO and 4 opened new positions — a net loss of 6 holders — while 14 trimmed existing stakes and 7 added.
The largest buyer was Dimensional Fund Advisors, adding an estimated $50K. The largest seller was BlackRock, cutting an estimated $574K.
- 49 institutional investors held Korro Bio (KRRO) as of Q4 2022, down from 55 in Q3 2022.
- Funds reported $28.1M of Korro Bio stock for Q4 2022, up 99% quarter-over-quarter.
- 4 funds opened new Korro Bio positions in Q4 2022 and 10 closed out, a net change of -6 holders.
- The largest Korro Bio buyer in Q4 2022 was Dimensional Fund Advisors, an estimated $50K added.
- The largest Korro Bio seller in Q4 2022 was BlackRock, an estimated $574K sold.
Based on aggregated 13F filings for Q4 2022.